annual D&A:
$7.01B+$723.00M(+11.49%)Summary
- As of today (May 29, 2025), PFE annual depreciation & amortization is $7.01 billion, with the most recent change of +$723.00 million (+11.49%) on December 31, 2024.
- During the last 3 years, PFE annual D&A has risen by +$1.82 billion (+35.10%).
- PFE annual D&A is now -22.30% below its all-time high of $9.03 billion, reached on December 31, 2011.
Performance
PFE Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$1.62B-$173.00M(-9.66%)Summary
- As of today (May 29, 2025), PFE quarterly depreciation & amortization is $1.62 billion, with the most recent change of -$173.00 million (-9.66%) on March 29, 2025.
- Over the past year, PFE quarterly D&A has dropped by -$118.00 million (-6.80%).
- PFE quarterly D&A is now -34.17% below its all-time high of $2.46 billion, reached on December 31, 2011.
Performance
PFE quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$6.89B-$118.00M(-1.68%)Summary
- As of today (May 29, 2025), PFE TTM depreciation & amortization is $6.89 billion, with the most recent change of -$118.00 million (-1.68%) on March 29, 2025.
- Over the past year, PFE TTM D&A has increased by +$356.00 million (+5.44%).
- PFE TTM D&A is now -24.59% below its all-time high of $9.14 billion, reached on March 1, 2012.
Performance
PFE TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
PFE Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.5% | -6.8% | +5.4% |
| 3 y3 years | +35.1% | +36.3% | +33.3% |
| 5 y5 years | +21.9% | +38.8% | +28.3% |
PFE Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +38.5% | -9.7% | +37.7% | -1.7% | +41.3% |
| 5 y | 5-year | at high | +46.8% | -9.7% | +38.8% | -1.7% | +46.6% |
| alltime | all time | -22.3% | +3286.3% | -34.2% | +3136.0% | -24.6% | >+9999.0% |
PFE Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $1.62B(-9.7%) | $6.89B(-1.7%) |
| Dec 2024 | $7.01B(+11.5%) | $1.79B(+2.1%) | $7.01B(+1.8%) |
| Sep 2024 | - | $1.75B(+1.4%) | $6.89B(+2.9%) |
| Jun 2024 | - | $1.73B(-0.3%) | $6.70B(+2.4%) |
| Mar 2024 | - | $1.74B(+4.0%) | $6.54B(+4.0%) |
| Dec 2023 | $6.29B(+24.2%) | $1.67B(+7.1%) | $6.29B(+2.5%) |
| Sep 2023 | - | $1.56B(-0.8%) | $6.14B(+6.5%) |
| Jun 2023 | - | $1.57B(+5.8%) | $5.76B(+7.4%) |
| Mar 2023 | - | $1.49B(-2.1%) | $5.36B(+5.9%) |
| Dec 2022 | $5.06B(-2.4%) | $1.52B(+28.4%) | $5.06B(+3.8%) |
| Sep 2022 | - | $1.18B(+0.7%) | $4.88B(-3.1%) |
| Jun 2022 | - | $1.18B(-1.0%) | $5.04B(-2.6%) |
| Mar 2022 | - | $1.19B(-11.1%) | $5.17B(-0.4%) |
| Dec 2021 | $5.19B(+8.7%) | $1.33B(-0.4%) | $5.19B(+2.6%) |
| Sep 2021 | - | $1.34B(+2.5%) | $5.06B(+2.7%) |
| Jun 2021 | - | $1.31B(+8.4%) | $4.93B(+2.3%) |
| Mar 2021 | - | $1.21B(+0.2%) | $4.82B(+0.9%) |
| Dec 2020 | $4.78B(-17.0%) | $1.20B(-0.3%) | $4.78B(+1.6%) |
| Sep 2020 | - | $1.21B(+0.8%) | $4.70B(-6.8%) |
| Jun 2020 | - | $1.20B(+2.8%) | $5.05B(-6.1%) |
| Mar 2020 | - | $1.17B(+3.3%) | $5.38B(-6.6%) |
| Dec 2019 | $5.75B(-6.4%) | $1.13B(-27.3%) | $5.75B(-4.6%) |
| Sep 2019 | - | $1.55B(+1.6%) | $6.03B(-1.0%) |
| Jun 2019 | - | $1.53B(-1.1%) | $6.09B(-0.6%) |
| Mar 2019 | - | $1.54B(+9.8%) | $6.13B(-0.4%) |
| Dec 2018 | $6.15B(-1.9%) | $1.41B(-12.8%) | $6.15B(-2.6%) |
| Sep 2018 | - | $1.61B(+3.3%) | $6.32B(+0.8%) |
| Jun 2018 | - | $1.56B(-0.3%) | $6.27B(-0.2%) |
| Mar 2018 | - | $1.57B(-0.4%) | $6.28B(+0.2%) |
| Dec 2017 | $6.27B(+8.9%) | $1.57B(+0.5%) | $6.27B(+0.4%) |
| Sep 2017 | - | $1.57B(-0.5%) | $6.24B(+2.8%) |
| Jun 2017 | - | $1.57B(+1.2%) | $6.07B(+3.2%) |
| Mar 2017 | - | $1.55B(+0.4%) | $5.89B(+2.3%) |
| Dec 2016 | $5.76B(+11.6%) | $1.55B(+11.0%) | $5.76B(+2.2%) |
| Sep 2016 | - | $1.40B(+0.6%) | $5.63B(+2.3%) |
| Jun 2016 | - | $1.39B(-2.7%) | $5.51B(+3.5%) |
| Mar 2016 | - | $1.43B(+0.1%) | $5.32B(+3.2%) |
| Dec 2015 | $5.16B(-6.9%) | $1.42B(+11.9%) | $5.16B(+1.8%) |
| Sep 2015 | - | $1.27B(+5.9%) | $5.06B(-1.1%) |
| Jun 2015 | - | $1.20B(-4.7%) | $5.12B(-4.2%) |
| Mar 2015 | - | $1.26B(-5.3%) | $5.34B(-3.5%) |
| Dec 2014 | $5.54B(-13.6%) | $1.33B(+0.4%) | $5.54B(-2.8%) |
| Sep 2014 | - | $1.33B(-6.9%) | $5.70B(-3.3%) |
| Jun 2014 | - | $1.42B(-2.2%) | $5.89B(-3.3%) |
| Mar 2014 | - | $1.46B(-2.2%) | $6.09B(-5.0%) |
| Dec 2013 | $6.41B(-16.3%) | $1.49B(-2.1%) | $6.41B(-8.8%) |
| Sep 2013 | - | $1.52B(-6.5%) | $7.03B(-1.9%) |
| Jun 2013 | - | $1.63B(-8.3%) | $7.16B(-0.6%) |
| Mar 2013 | - | $1.77B(-15.8%) | $7.21B(-5.8%) |
| Dec 2012 | $7.66B(-15.2%) | $2.11B(+27.2%) | $7.66B(-4.4%) |
| Sep 2012 | - | $1.66B(-0.9%) | $8.01B(-6.5%) |
| Jun 2012 | - | $1.67B(-24.8%) | $8.56B(-6.3%) |
| Mar 2012 | - | $2.22B(-9.6%) | $9.14B(+1.3%) |
| Dec 2011 | $9.03B(+7.5%) | $2.46B(+11.0%) | $9.03B(+6.5%) |
| Sep 2011 | - | $2.21B(-1.5%) | $8.47B(-0.2%) |
| Jun 2011 | - | $2.25B(+6.9%) | $8.49B(+0.4%) |
| Mar 2011 | - | $2.10B(+10.4%) | $8.45B(+0.6%) |
| Dec 2010 | $8.40B(+76.6%) | $1.91B(-14.5%) | $8.40B(+1.6%) |
| Sep 2010 | - | $2.23B(+0.7%) | $8.27B(+18.0%) |
| Jun 2010 | - | $2.21B(+7.9%) | $7.01B(+20.8%) |
| Mar 2010 | - | $2.05B(+15.6%) | $5.80B(+21.9%) |
| Dec 2009 | $4.76B(-6.5%) | $1.77B(+83.1%) | $4.76B(+14.3%) |
| Sep 2009 | - | $969.00M(-3.7%) | $4.16B(-5.2%) |
| Jun 2009 | - | $1.01B(-0.2%) | $4.39B(-4.8%) |
| Mar 2009 | - | $1.01B(-14.4%) | $4.61B(-9.4%) |
| Dec 2008 | $5.09B(-2.1%) | $1.18B(-1.5%) | $5.09B(+1.2%) |
| Sep 2008 | - | $1.20B(-2.7%) | $5.03B(-3.4%) |
| Jun 2008 | - | $1.23B(-17.4%) | $5.20B(-3.9%) |
| Mar 2008 | - | $1.49B(+33.2%) | $5.42B(+4.2%) |
| Dec 2007 | $5.20B | $1.12B(-18.7%) | $5.20B(-2.8%) |
| Sep 2007 | - | $1.37B(-4.8%) | $5.35B(+0.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2007 | - | $1.44B(+13.4%) | $5.31B(+1.9%) |
| Mar 2007 | - | $1.27B(+0.3%) | $5.21B(-1.5%) |
| Dec 2006 | $5.29B(-5.1%) | $1.27B(-4.9%) | $5.29B(-3.0%) |
| Sep 2006 | - | $1.33B(-0.8%) | $5.46B(-0.6%) |
| Jun 2006 | - | $1.34B(-0.6%) | $5.49B(-1.2%) |
| Mar 2006 | - | $1.35B(-5.7%) | $5.56B(-0.3%) |
| Dec 2005 | $5.58B(+9.5%) | $1.43B(+4.8%) | $5.58B(+2.2%) |
| Sep 2005 | - | $1.37B(-3.0%) | $5.45B(+1.9%) |
| Jun 2005 | - | $1.41B(+3.2%) | $5.35B(+3.0%) |
| Mar 2005 | - | $1.37B(+4.2%) | $5.20B(+2.1%) |
| Dec 2004 | $5.09B(+26.5%) | $1.31B(+3.6%) | $5.09B(-7.5%) |
| Sep 2004 | - | $1.26B(+0.7%) | $5.50B(+3.1%) |
| Jun 2004 | - | $1.26B(-0.4%) | $5.34B(+6.4%) |
| Mar 2004 | - | $1.26B(-26.8%) | $5.02B(+24.6%) |
| Dec 2003 | $4.03B(+288.5%) | $1.72B(+56.8%) | $4.03B(+54.6%) |
| Sep 2003 | - | $1.10B(+17.3%) | $2.60B(+48.3%) |
| Jun 2003 | - | $936.00M(+248.0%) | $1.75B(+65.7%) |
| Mar 2003 | - | $269.00M(-10.3%) | $1.06B(+2.2%) |
| Dec 2002 | $1.04B(+6.6%) | $300.00M(+20.0%) | $1.04B(+10.7%) |
| Sep 2002 | - | $250.00M(+4.2%) | $936.00M(0.0%) |
| Jun 2002 | - | $240.00M(-2.4%) | $936.00M(-2.9%) |
| Mar 2002 | - | $246.00M(+23.0%) | $964.00M(-0.8%) |
| Dec 2001 | $972.00M(+0.4%) | $200.00M(-20.0%) | $972.00M(-5.9%) |
| Sep 2001 | - | $250.00M(-6.7%) | $1.03B(+1.6%) |
| Jun 2001 | - | $268.00M(+5.5%) | $1.02B(+4.0%) |
| Mar 2001 | - | $254.00M(-2.7%) | $978.00M(+1.0%) |
| Dec 2000 | $968.00M(+7.0%) | $261.00M(+11.5%) | $968.00M(-0.5%) |
| Sep 2000 | - | $234.00M(+2.2%) | $973.00M(+0.8%) |
| Jun 2000 | - | $229.00M(-6.1%) | $965.00M(-5.5%) |
| Mar 2000 | - | $244.00M(-8.3%) | $1.02B(+12.8%) |
| Dec 1999 | $905.00M(+13.6%) | $266.00M(+17.7%) | $905.00M(-8.8%) |
| Sep 1999 | - | $226.00M(-20.7%) | $992.00M(+1.7%) |
| Jun 1999 | - | $285.00M(+122.7%) | $975.00M(+20.8%) |
| Mar 1999 | - | $128.00M(-63.7%) | $807.00M(+1.3%) |
| Dec 1998 | $797.00M(+86.2%) | $353.00M(+68.9%) | $797.00M(+44.1%) |
| Sep 1998 | - | $209.00M(+78.6%) | $553.00M(+32.0%) |
| Jun 1998 | - | $117.00M(-0.8%) | $419.00M(-3.0%) |
| Mar 1998 | - | $118.00M(+8.3%) | $432.00M(+0.9%) |
| Dec 1997 | $428.00M(+19.2%) | $109.00M(+45.3%) | $428.00M(+16.0%) |
| Sep 1997 | - | $75.00M(-42.3%) | $369.00M(-6.8%) |
| Jun 1997 | - | $130.00M(+14.0%) | $396.00M(+6.5%) |
| Mar 1997 | - | $114.00M(+128.0%) | $372.00M(+3.6%) |
| Dec 1996 | $359.00M(-4.0%) | $50.00M(-51.0%) | $359.00M(-13.9%) |
| Sep 1996 | - | $102.00M(-3.8%) | $416.80M(+4.2%) |
| Jun 1996 | - | $106.00M(+5.0%) | $400.10M(+11.3%) |
| Mar 1996 | - | $101.00M(-6.3%) | $359.40M(-3.9%) |
| Dec 1995 | $374.00M(+28.1%) | $107.80M(+26.4%) | $374.00M(+8.5%) |
| Sep 1995 | - | $85.30M(+30.6%) | $344.60M(+3.4%) |
| Jun 1995 | - | $65.30M(-43.5%) | $333.40M(-0.9%) |
| Mar 1995 | - | $115.60M(+47.4%) | $336.50M(+15.2%) |
| Dec 1994 | $292.00M(+13.1%) | $78.40M(+5.8%) | $292.00M(+4.1%) |
| Sep 1994 | - | $74.10M(+8.3%) | $280.60M(+3.0%) |
| Jun 1994 | - | $68.40M(-3.8%) | $272.50M(+2.0%) |
| Mar 1994 | - | $71.10M(+6.1%) | $267.20M(+3.5%) |
| Dec 1993 | $258.20M(-2.2%) | $67.00M(+1.5%) | $258.20M(+0.9%) |
| Sep 1993 | - | $66.00M(+4.6%) | $256.00M(-1.1%) |
| Jun 1993 | - | $63.10M(+1.6%) | $258.90M(-0.5%) |
| Mar 1993 | - | $62.10M(-4.2%) | $260.30M(-1.4%) |
| Dec 1992 | $263.90M(+8.1%) | $64.80M(-6.0%) | $263.90M(+2.0%) |
| Sep 1992 | - | $68.90M(+6.8%) | $258.80M(+3.1%) |
| Jun 1992 | - | $64.50M(-1.8%) | $250.90M(+1.0%) |
| Mar 1992 | - | $65.70M(+10.1%) | $248.50M(+1.8%) |
| Dec 1991 | $244.10M(+8.6%) | $59.70M(-2.1%) | $244.10M(+1.4%) |
| Sep 1991 | - | $61.00M(-1.8%) | $240.70M(+1.8%) |
| Jun 1991 | - | $62.10M(+1.3%) | $236.40M(+3.2%) |
| Mar 1991 | - | $61.30M(+8.9%) | $229.00M(+1.9%) |
| Dec 1990 | $224.80M(+8.5%) | $56.30M(-0.7%) | $224.80M(+33.4%) |
| Sep 1990 | - | $56.70M(+3.7%) | $168.50M(+50.7%) |
| Jun 1990 | - | $54.70M(-4.2%) | $111.80M(+95.8%) |
| Mar 1990 | - | $57.10M | $57.10M |
| Dec 1989 | $207.10M | - | - |
FAQ
- What is Pfizer annual depreciation & amortization?
- What is the all time high annual D&A for Pfizer?
- What is Pfizer annual D&A year-on-year change?
- What is Pfizer quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Pfizer?
- What is Pfizer quarterly D&A year-on-year change?
- What is Pfizer TTM depreciation & amortization?
- What is the all time high TTM D&A for Pfizer?
- What is Pfizer TTM D&A year-on-year change?
What is Pfizer annual depreciation & amortization?
The current annual D&A of PFE is $7.01B
What is the all time high annual D&A for Pfizer?
Pfizer all-time high annual depreciation & amortization is $9.03B
What is Pfizer annual D&A year-on-year change?
Over the past year, PFE annual depreciation & amortization has changed by +$723.00M (+11.49%)
What is Pfizer quarterly depreciation & amortization?
The current quarterly D&A of PFE is $1.62B
What is the all time high quarterly D&A for Pfizer?
Pfizer all-time high quarterly depreciation & amortization is $2.46B
What is Pfizer quarterly D&A year-on-year change?
Over the past year, PFE quarterly depreciation & amortization has changed by -$118.00M (-6.80%)
What is Pfizer TTM depreciation & amortization?
The current TTM D&A of PFE is $6.89B
What is the all time high TTM D&A for Pfizer?
Pfizer all-time high TTM depreciation & amortization is $9.14B
What is Pfizer TTM D&A year-on-year change?
Over the past year, PFE TTM depreciation & amortization has changed by +$356.00M (+5.44%)